Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
April 30, 2024 - Page 2 of 5 - The Dermatology Digest
Subscribe
Search

Day: April 30, 2024

AD Pipeline Update: Eli Lilly Resubmits BLA for Lebrikizumab in AD

Eli Lilly has resubmitted its Biologics License Application (BLA) for Lebrikizumab for the treatment of moderate to severe atopic dermatitis (AD), with regulatory action anticipated in the second half of 2024. The Company announced  the news along with its financial results for the first quarter of 2024 during a live webcast. Lebrikizumab is subcutaneous recombinant humanized IgG4 […]